Dow Jones
34.189,22 +276,78 (+0,82%) Nasdaq
13.114,86 -13,19 (-0,10%) Nikkei 225
28.868,91 -2,87 (-0,01%) EUR/USD
1,0173 +0,0008 (+0,08%) BTC-EUR
23.458,76 -537,37 (-2,24%) CMC Crypto 200
567,26 -4,66 (-0,81%)
Fluxys Belgium SA (0Q7U.L)
| Chiusura precedente | 30,00 |
| Aperto | 30,00 |
| Denaro | 0,00 x N/D |
| Lettera | 0,00 x N/D |
| Min-Max giorno | 30,00 - 30,30 |
| Intervallo di 52 settimane | 30,00 - 30,30 |
| Volume | |
| Media Volume | N/D |
| Capitalizzazione | N/D |
| Beta (5 anni mensile) | 0,25 |
| Rapporto PE (ttm) | 0,25 |
| EPS (ttm) | 1,08 |
| Prossima data utili | N/D |
| Rendimento e dividendo (forward) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
- GlobeNewswire
Pelorus Equity Group Closes $11.8 Million Debt Financing, Enabling Juva Life to Expand Cannabis Operations, Further Clinical Research
NEWPORT BEACH, Calif., June 21, 2022 (GLOBE NEWSWIRE) -- Pelorus Equity Group (“Pelorus”), the leading provider of commercial real estate loans for the cannabis sector, announced it has closed an $11.8 million financing with Juva Life Inc. (“Juva Life,” “Juva” or the “Company”), a life science company with pharmaceutical research and development and consumer-facing operations in cannabis production and distribution. The primary purpose of the financing, which closed on June 15, 2022, is to finan
- GlobeNewswire
Juva Life Secures $11.8 Million in Financing, Enabling Expansion of Cannabis Operations, Further Clinical Research
Cannabis and Life Sciences Company Closes $11.8 Million in Non-Dilutive Debt FinancingVANCOUVER, British Columbia, June 21, 2022 (GLOBE NEWSWIRE) -- Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva” or the “Company”), a life science company with pharmaceutical research and development and consumer-facing operations in cannabis production and distribution, announced today that it has closed a non-dilutive financing of $11.8 million, enabling the Company to acquire it
- GlobeNewswire
Fluxys Belgium – 8 April 2022 13:00 CET - Regulated information: ordinary and extraordinary general meetings on 10 May 2022
The Board of Directors of Fluxys Belgium SA has the honour to invite the shareholders of the company to attend the ordinary and extraordinary general meetings to be held on Tuesday 10 May 2022 from 2.30 pm at the company's registered office, Kunstlaan 31, 1040 Brussels. Shareholders who wish to do so will also be able to participate remotely via videoconference according to the modalities defined in the notice of meeting for the meetings. Download below the notice of meeting for the ordinary and
